Fosphenytoin Injection, Solution
Product Images NDC 63323-403

7 FDA label images from Fresenius Kabi Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Fosphenytoin (NDC 63323-403). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular Structure Of Fosphenytoin (Fos05 0007 01)

Molecular Structure Of Fosphenytoin (Fos05 0007 01)
Chemical structure of Fosphenytoin sodium salt, showing the molecular arrangement of atoms including nitrogen, oxygen, phosphorus, and sodium ions.*
FDA Label Image

Figure 1 (Fos05 0007 02)

Figure 1 (Fos05 0007 02)
A line graph depicting plasma unbound phenytoin concentration (mg/mL) over time after start of infusion (hours). The main graph shows data from 0 to 2 hours, with three different symbols representing distinct data sets. An inset graph displays plasma unbound phenytoin concentration over a longer period (0 to 96 hours), showing a decline over time.*
FDA Label Image

Fresenius Kabi Logo (Fos05 0007 03)

FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
Fosphenytoin Sodium Injection, USP, 50 mg/mL (100 mg PE per 2 mL) in a 2 mL single dose vial. The label indicates refrigeration storage at 2°C to 8°C (36°F to 46°F) and specifies use for intramuscular or intravenous administration. The product is labeled Rx only and manufactured by Fresenius Kabi USA, LLC.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
Label for Fosphenytoin Sodium Injection USP, 50 mg PE per mL (100 mg PE per 2 mL) in single-dose vials. The label specifies intramuscular or intravenous use, with storage instructions to refrigerate at 2°C to 8°C. It is produced by Fresenius Kabi USA, LLC, Lake Zurich, IL, and includes barcodes along with information on ingredients and dosage equivalency to phenytoin sodium.*
FDA Label Image

Package Label – Principal Display – Fosphenytoin 10 mL Single Dose Vial Label (Fos05 0007 06)

Package Label – Principal Display – Fosphenytoin 10 mL Single Dose Vial Label (Fos05 0007 06)
Fosphenytoin Sodium Injection USP 50 mg/mL (500 mg phenytoin sodium equivalent per 10 mL) in a 10 mL single-dose vial. Label shows sterile product for intramuscular or intravenous use, by Fresenius Kabi USA, LLC. Includes storage instructions to refrigerate at 2°C to 8°C (36°F to 46°F).*
FDA Label Image

Package Label – Principal Display – Fosphenytoin 10 mL Single Dose Vial Tray Label (Fos05 0007 07)

Package Label – Principal Display – Fosphenytoin 10 mL Single Dose Vial Tray Label (Fos05 0007 07)
Fosphenytoin Sodium Injection, USP labeling showing 500 mg PE per 10 mL (50 mg PE per mL) strength, indicating phenytoin sodium equivalents. The label specifies intramuscular or intravenous use, single dose vials of 10x10 mL, and refrigeration storage. The labeler is Fresenius Kabi USA, LLC, Lake Zurich, IL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.